← ICU MEDICAL INC/DE
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | $63.1m |
$68.6m
+8.81%
|
$28.8m
-58.05%
|
$101.0m
+250.90%
|
$86.9m
-14.02%
|
$103.1m
+18.72%
|
($74.3m)
-172.03%
|
($29.7m)
+60.08%
|
($117.7m)
-296.86%
|
$732k
+100.62%
|
— | |
| Depreciation, Depletion and Amortization | $19.1m | $66.6m | $74.7m | $76.9m | $85.6m | $89.7m | $235.2m | $228.8m | $219.5m | $200.7m | $201.3m | |
| Depreciation | $16.3m | $51.6m | $58.1m | $59.3m | $62.4m | $65.9m | $95.8m | $96.7m | $85.2m | $69.3m | $201.3m | |
| Amortization of Debt Issuance Costs | $0 | $48k | $288k | $288k | $288k | $240k | $7.0m | $6.8m | $6.8m | $6.2m | — | |
| Amortization of Intangible Assets | $2.8m | $15.0m | $16.6m | $17.7m | $23.2m | $23.8m | $139.4m | $132.1m | $134.3m | $131.4m | — | |
| Deferred Income Tax Expense (Benefit) | ($2.5m) | ($25.6m) | ($17.9m) | ($3.7m) | ($5.1m) | ($11.3m) | ($61.0m) | ($71.5m) | $5.7m | ($13.8m) | — | |
| Share-based Payment Arrangement, Noncash Expense | $15.2m | $19.4m | $24.2m | $21.9m | $24.0m | $27.3m | $36.0m | $40.6m | $46.9m | $55.8m | $55.0m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | $1.9m | $4.1m | $6.3m | $18.6m | $12.9m | $8.3m | $10.9m | $9.4m | $12.0m | $8.8m | — | |
| Goodwill, Impairment Loss | $0 | — | — | — | — | — | — | — | — | — | — | |
| Impairment of Intangible Assets, Finite-lived | — | — | $5.0m | $0 | $0 | — | — | — | — | — | — | |
| Income (Loss) from Equity Method Investments | — | — | — | — | — | — | — | $0 | $0 | ($1.2m) | — | |
| Nonoperating Income (Expense) | $767k | ($2.5m) | $1.5m | $7.9m | $1.1m | $799k | ($5.1m) | ($5.9m) | ($13.2m) | ($232k) | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | ($744k) | $54.5m | $76.7m | $23.7m | ($78.0m) | ($13.8m) | $19.2m | ($48.6m) | $46.8m | ($8.9m) | ($15.4m) | |
| Increase (Decrease) in Inventories | $5.5m | ($181.7m) | $21.8m | $25.0m | ($19.2m) | ($20.8m) | $201.1m | $6.1m | ($16.8m) | $26.3m | $7.6m | |
| Increase (Decrease) in Accounts Payable | ($463k) | $46.6m | $23.3m | ($2.7m) | ($46.4m) | $2.3m | $37.5m | ($68.3m) | $12.5m | $7.0m | ($12.3m) | |
| Gain (Loss) on Disposition of Other Assets | — | — | — | — | $0 | $0 | ($2.6m) | ($153k) | ($1.6m) | ($4.4m) | — | |
| Net Cash Provided by (Used in) Operating Activities | $89.9m |
$154.4m
+71.69%
|
$160.2m
+3.75%
|
$101.9m
-36.39%
|
$222.8m
+118.56%
|
$267.5m
+20.11%
|
($62.1m)
-123.22%
|
$166.2m
+367.51%
|
$204.0m
+22.76%
|
$179.8m
-11.85%
|
$236.4m
+31.43%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $23.4m | $74.5m | $92.7m | $97.3m | $92.0m | $68.5m | $90.3m | $83.9m | $79.4m | $88.0m | ($91.5m) | |
| Gain (Loss) on Disposition of Property Plant Equipment | ($59k) | ($3.8m) | ($8.9m) | ($12.9m) | $1.8m | ($1.7m) | ($2.0m) | ($2.1m) | ($2.5m) | ($5.9m) | $7.2m | |
| Cash, Cash Equivalents, and Short-term Investments | $445.1m | $300.1m | $382.1m | $292.6m | $410.8m | $567.2m | $213.0m | $254.7m | $308.6m | — | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | $2.6m | $162.4m | $1.3m | $76.1m | $0 | $14.5m | $1.8b | $0 | $0 | — | $0 | |
| Net Cash Provided by (Used in) Investing Activities | $16.3m | ($266.9m) | ($103.4m) | ($166.9m) | ($98.1m) | ($90.7m) | ($1.9b) | ($87.9m) | ($89.0m) | $122.2m | ($79.8m) | |
| Cash flows from financing activities: | ||||||||||||
| Repayments of Long-term Debt | — | $75.0m | $0 | $0 | $150.0m | $0 | $22.4m | $29.7m | $51.0m | $302.8m | ($112.1m) | |
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | — | — | — | $0 | $0 | ($2.5m) | — | |
| Payments for Repurchase of Common Stock | $17.2m | $4.1m | $6.3m | $18.6m | $12.9m | $8.3m | $10.9m | $9.3m | $12.0m | $8.8m | — | |
| Net Cash Provided by (Used in) Financing Activities | $2.5m |
($44.3m)
-1894.05%
|
$8.0m
+118.09%
|
($10.9m)
-235.95%
|
($40k)
+99.63%
|
($16.9m)
-42075.00%
|
$1.6b
+9803.81%
|
($36.0m)
-102.20%
|
($55.8m)
-55.09%
|
($311.5m)
-458.29%
|
($154.5m)
+50.40%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | $54.7m | — | $127.4m | $156.7m | ($344.0m) | $45.4m | $54.3m | ($603k) | $302.1m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $54.7m | ($76.1m) | $127.4m | $156.7m | $208.8m | $254.2m | $308.6m | $308.0m | $302.1m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $54.7m | ($76.1m) | $127.4m | $156.7m | ($9.5m) | $3.2m | ($4.9m) | $8.8m | ($3.8m) | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $17.3m | $32.0m | $14.3m | $7.7m | $13.2m | $9.4m | $8.8m | $4.0m | $10.9m | $6.1m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $118k | $2.0m | $709k | $549k | $1.8m | $858k | $63.7m | $95.9m | $99.7m | $83.7m | — | |
| Additional Financial Items | ||||||||||||
| Derivative, Gain (Loss) on Derivative, Net | — | $885k | $743k | $916k | $790k | $3.4m | — | — | — | $14.4m | — | |
| Foreign Currency Transaction Gain (Loss), Realized | $300k | ($1.8m) | ($7.9m) | $700k | ($7.2m) | ($1.0m) | ($5.8m) | ($5.9m) | ($9.8m) | $3.8m | — | |
| Gain (Loss) on Disposition of Assets | $0 | $0 | — | — | $0 | $0 | $374k | $0 | $0 | ($44.8m) | — | |
| Gain (Loss) on Disposition of Business | — | — | — | — | $0 | $0 | $374k | $0 | $0 | $44.8m | — | |
| Goodwill | $5.6m | $12.4m | $11.2m | $31.2m | $33.0m | $43.4m | $1.4b | $1.5b | $1.4b | $1.5b | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | $85.2m | — | — | — | — | — | — | — | — | — | — | |
| Income Tax Expense (Benefit) | $22.1m | ($17.4m) | ($6.4m) | $13.7m | $10.6m | $20.1m | ($40.1m) | ($48.6m) | $51.7m | $2.4m | — | |
| Operating Expenses | $118.5m | $441.2m | $548.4m | $364.5m | $363.3m | $368.2m | $740.7m | $717.0m | $781.8m | $779.2m | — | |
| Restructuring Costs | $774k | $18.8m | $4.5m | $8.4m | $7.9m | $140k | $9.7m | $6.7m | $19.6m | $30.0m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.